Folkers K - Search Results

1

Hemostatic changes after dietary coenzyme Q10 supplementation in swine.

Serebruany VL, Herzog WR, Atamas SP, Gurbel PA, Rohde M, Mortensen SA, Folkers K. Serebruany VL, et al. Among authors: folkers k. J Cardiovasc Pharmacol. 1996 Aug;28(2):175-81. doi: 10.1097/00005344-199608000-00001. J Cardiovasc Pharmacol. 1996. PMID: 8856471

2

Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.

Serebruany VL, Ordonez JV, Herzog WR, Rohde M, Mortensen SA, Folkers K, Gurbel PA. Serebruany VL, et al. Among authors: folkers k. J Cardiovasc Pharmacol. 1997 Jan;29(1):16-22. doi: 10.1097/00005344-199701000-00003. J Cardiovasc Pharmacol. 1997. PMID: 9007665

3

Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?

Serebruany VL, Gurbel PA, Ordoñez JV, Herzog WR, Rohde M, Mortensen SA, Folkers K. Serebruany VL, et al. Among authors: folkers k. Mol Aspects Med. 1997;18 Suppl:S189-94. doi: 10.1016/s0098-2997(97)00012-5. Mol Aspects Med. 1997. PMID: 9266521

4

Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.

Folkers K, Vadhanavikit S, Mortensen SA. Folkers K, et al. Proc Natl Acad Sci U S A. 1985 Feb;82(3):901-4. doi: 10.1073/pnas.82.3.901. Proc Natl Acad Sci U S A. 1985. PMID: 3856239 Free PMC article.

5

Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure.

Mortensen SA, Vadhanavikit S, Muratsu K, Folkers K. Mortensen SA, et al. Among authors: folkers k. Int J Tissue React. 1990;12(3):155-62. Int J Tissue React. 1990. PMID: 2276893 Review.

6

Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.

Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Mortensen SA, et al. Among authors: folkers k. Drugs Exp Clin Res. 1985;11(8):581-93. Drugs Exp Clin Res. 1985. PMID: 3836876

7

Survival of cancer patients on therapy with coenzyme Q10.

Folkers K, Brown R, Judy WV, Morita M. Folkers K, et al. Biochem Biophys Res Commun. 1993 Apr 15;192(1):241-5. doi: 10.1006/bbrc.1993.1405. Biochem Biophys Res Commun. 1993. PMID: 8476426 Review.

8

The activities of coenzyme Q10 and vitamin B6 for immune responses.

Folkers K, Morita M, McRee J Jr. Folkers K, et al. Biochem Biophys Res Commun. 1993 May 28;193(1):88-92. doi: 10.1006/bbrc.1993.1593. Biochem Biophys Res Commun. 1993. PMID: 8503942 Clinical Trial.

9

The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men.

Porter DA, Costill DL, Zachwieja JJ, Krzeminski K, Fink WJ, Wagner E, Folkers K. Porter DA, et al. Among authors: folkers k. Int J Sports Med. 1995 Oct;16(7):421-7. doi: 10.1055/s-2007-973031. Int J Sports Med. 1995. PMID: 8550248 Clinical Trial.

10

Myocardial preservation by therapy with coenzyme Q10 during heart surgery.

Judy WV, Stogsdill WW, Folkers K. Judy WV, et al. Among authors: folkers k. Clin Investig. 1993;71(8 Suppl):S155-61. doi: 10.1007/BF00226859. Clin Investig. 1993. PMID: 8241702 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters